This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: University of Southern California, Memorial Sloan Kettering Cancer Center, The University of North Carolina at Chapel Hill. Active years: 2023-2026.
Company Filing History:
2 out of 1,691 
1 out of 617 
1 out of 1,324 
Years Active: 2023-2026
Title: Vsevolod Katritch: Innovator in Pain Relief
Introduction
Vsevolod Katritch is a notable inventor based in Los Angeles, California. He has made significant contributions to the field of pharmacology, particularly in the development of pain relief medications. His innovative work focuses on creating compounds that offer improved therapeutic profiles compared to traditional opioids.
Latest Patents
Katritch holds a patent for a G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment. This patent outlines compounds that may be utilized to alleviate pain in patients. The compounds described in the patent demonstrate an enhanced pharmaceutical profile relative to commonly used opiates and opioid derivatives, potentially offering safer and more effective pain management options.
Career Highlights
Throughout his career, Vsevolod Katritch has worked with esteemed institutions such as the University of Health Sciences and Pharmacy in St. Louis and the University of Southern California. His research has focused on the mechanisms of opioid receptors and their implications for pain relief.
Collaborations
Some of his notable collaborators include Susruta Majumdar and Bryan Leo Roth. Their combined expertise has contributed to advancements in the understanding of opioid pharmacology.
Conclusion
Vsevolod Katritch's innovative work in the field of pain relief exemplifies the potential for new therapeutic approaches in medicine. His contributions continue to influence the development of safer and more effective analgesics.